Determination That M.V.I. PEDIATRIC (Multiple Vitamins for Injection) Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
Official abstract: The Food and Drug Administration (FDA, Agency, or we) has determined that M.V.I. PEDIATRIC (ascorbic acid 80 milligrams (mg)/ vial; biotin 0.02 mg/vial; cyanocobalamin 0.001 mg/vial; dexpanthenol 5 mg/vial; ergocalciferol 0.01 mg/vial; folic acid 0.14 mg/vial; niacinamide 17 mg/vial; phytonadione 0.2 mg/vial; pyridoxine hydrochloride 1 mg/vial; riboflavin 5'-phosphate sodium 1.4 mg/vial; thiamine hydrochloride equivalent (EQ) 1.2 mg base/vial; vitamin A 0.7 mg/vial; vitamin E 7 mg/vial), for injection, was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for ascorbic acid 80 mg/vial; biotin 0.02 mg/vial; cyanocobalamin 0.001 mg/ vial; dexpanthenol 5 mg/vial; ergocalciferol 0.01 mg/vial; folic acid 0.14 mg/vial; niacinamide 17 mg/vial; phytonadione 0.2 mg/vial; pyridoxine hydrochloride 1 mg/vial; riboflavin 5'-phosphate sodium 1.4 mg/vial; thiamine hydrochloride EQ 1.2 mg base/vial; vitamin A 0.7 mg/ vial; vitamin E 7 mg/vial, for injection, if all other legal and regulatory requirements are met.